BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32890696)

  • 1. Differential effects of cannabis exposure during early versus later adolescence on the expression of psychosis in homeless and precariously housed adults.
    Gicas KM; Cheng A; Panenka WJ; Kim DD; Yau JC; Procyshyn RM; Stubbs JL; Jones AA; Bains S; Thornton AE; Lang DJ; Vertinsky AT; Rauscher A; Honer WG; Barr AM
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110084. PubMed ID: 32890696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychopathologic differences between cannabis-induced psychoses and recent-onset primary psychoses with abuse of cannabis.
    Rubio G; Marín-Lozano J; Ferre F; Martínez-Gras I; Rodriguez-Jimenez R; Sanz J; Jimenez-Arriero MA; Carrasco JL; Lora D; Jurado R; López-Trabada JR; Palomo T
    Compr Psychiatry; 2012 Nov; 53(8):1063-70. PubMed ID: 22682680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of sex on substance use between first episode psychosis patients and healthy people.
    Núñez C; Ochoa S; Huerta-Ramos E; Baños I; Barajas A; Dolz M; Sánchez B; Del Cacho N; ; Usall J
    Compr Psychiatry; 2016 Aug; 69():169-78. PubMed ID: 27423358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study.
    Delvecchio G; Oldani L; Mandolini GM; Pigoni A; Ciappolino V; Schiena G; Lazzaretti M; Caletti E; Barbieri V; Cinnante C; Triulzi F; Brambilla P
    J Vis Exp; 2020 Aug; (162):. PubMed ID: 32894263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of substance use, psychosis, and mortality among people living in precarious housing or homelessness: A longitudinal, community-based study in Vancouver, Canada.
    Jones AA; Gicas KM; Seyedin S; Willi TS; Leonova O; Vila-Rodriguez F; Procyshyn RM; Smith GN; Schmitt TA; Vertinsky AT; Buchanan T; Rauscher A; Lang DJ; MacEwan GW; Lima VD; Montaner JSG; Panenka WJ; Barr AM; Thornton AE; Honer WG
    PLoS Med; 2020 Jul; 17(7):e1003172. PubMed ID: 32628679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome.
    Auther AM; McLaughlin D; Carrión RE; Nagachandran P; Correll CU; Cornblatt BA
    Psychol Med; 2012 Dec; 42(12):2485-97. PubMed ID: 22716931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample.
    Auther AM; Cadenhead KS; Carrión RE; Addington J; Bearden CE; Cannon TD; McGlashan TH; Perkins DO; Seidman L; Tsuang M; Walker EF; Woods SW; Cornblatt BA
    Acta Psychiatr Scand; 2015 Jul; 132(1):60-8. PubMed ID: 25572323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cannabis and psychosis: search of a causal link through a critical and systematic review].
    Le Bec PY; Fatséas M; Denis C; Lavie E; Auriacombe M
    Encephale; 2009 Sep; 35(4):377-85. PubMed ID: 19748375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salience attribution and its relationship to cannabis-induced psychotic symptoms.
    Bloomfield MA; Mouchlianitis E; Morgan CJ; Freeman TP; Curran HV; Roiser JP; Howes OD
    Psychol Med; 2016 Dec; 46(16):3383-3395. PubMed ID: 27628967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of regional brain volumes and white matter connectivity in subjects with stimulant induced psychosis versus schizophrenia.
    Alexander PD; Gicas KM; Cheng A; Lang DJ; Procyshyn RM; Vertinsky AT; Panenka WJ; Thornton AE; Rauscher A; Wong JYX; Chan T; Jones AA; Vila-Rodriguez F; Honer WG; Barr AM
    Psychopharmacology (Berl); 2019 Dec; 236(12):3385-3399. PubMed ID: 31230145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annual incidence of cannabis-induced psychosis, other substance-induced psychoses and dually diagnosed schizophrenia and cannabis use disorder in Denmark from 1994 to 2016.
    Hjorthøj C; Larsen MO; Starzer MSK; Nordentoft M
    Psychol Med; 2021 Mar; 51(4):617-622. PubMed ID: 31839011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in associations between cannabis and stimulant disorders in first admission psychosis.
    Sara G; Burgess P; Malhi GS; Whiteford H; Hall W
    Schizophr Res; 2013 Jul; 147(2-3):216-22. PubMed ID: 23684162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A neuropsychological approach to differentiating cannabis-induced and primary psychotic disorders.
    Woolridge SM; Wood-Ross C; Voleti R; Harrison GW; Berisha V; Bowie CR
    Early Interv Psychiatry; 2023 Jun; 17(6):564-572. PubMed ID: 37280059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychoses.
    Caton CL; Drake RE; Hasin DS; Dominguez B; Shrout PE; Samet S; Schanzer B
    Arch Gen Psychiatry; 2005 Feb; 62(2):137-45. PubMed ID: 15699290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing hypotheses about the relationship between cannabis use and psychosis.
    Degenhardt L; Hall W; Lynskey M
    Drug Alcohol Depend; 2003 Jul; 71(1):37-48. PubMed ID: 12821204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial predisposition for psychiatric disorder: comparison of subjects treated for cannabis-induced psychosis and schizophrenia.
    Arendt M; Mortensen PB; Rosenberg R; Pedersen CB; Waltoft BL
    Arch Gen Psychiatry; 2008 Nov; 65(11):1269-74. PubMed ID: 18981338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis use in early psychosis is associated with reduced glutamate levels in the prefrontal cortex.
    Rigucci S; Xin L; Klauser P; Baumann PS; Alameda L; Cleusix M; Jenni R; Ferrari C; Pompili M; Gruetter R; Do KQ; Conus P
    Psychopharmacology (Berl); 2018 Jan; 235(1):13-22. PubMed ID: 29075884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early exposure to cannabis and risk for psychosis in young adolescents in Trinidad.
    Konings M; Henquet C; Maharajh HD; Hutchinson G; Van Os J
    Acta Psychiatr Scand; 2008 Sep; 118(3):209-13. PubMed ID: 18452569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis use in psychotic patients.
    Sembhi S; Lee JW
    Aust N Z J Psychiatry; 1999 Aug; 33(4):529-32. PubMed ID: 10483847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
    Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
    Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.